335 related articles for article (PubMed ID: 16025230)
1. Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Voors AA; de Kam PJ; van den Berg MP; Borghi C; Hochman JS; van Veldhuisen DJ; van Gilst WH
Cardiovasc Drugs Ther; 2005 Mar; 19(2):119-24. PubMed ID: 16025230
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitors: should they be used early post myocardial infarction?
Pitt B
Cardiovasc Drugs Ther; 2005 Mar; 19(2):103-4. PubMed ID: 16025227
[No Abstract] [Full Text] [Related]
4. [Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
Konermann M; Odenthal HJ; Altmann C; Laschewski F; Rawert B; Trappe HJ; Sanner BM
Wien Med Wochenschr; 2000; 150(12):249-55. PubMed ID: 11008329
[TBL] [Abstract][Full Text] [Related]
5. [The impact of nitrates and mono-therapy and nitrates combined with angiotensin converting enzyme inhibitors on left ventricular remodeling and exercise capacity in patients after acute myocardial infarction].
Maciejewicz J; Maziarz A; Celibała R; Wiśniewski M; Wiśniewska M
Przegl Lek; 2003; 60(2):80-4. PubMed ID: 12939852
[TBL] [Abstract][Full Text] [Related]
6. Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants.
Michaels AD; Maynard C; Every NR; Barron HV
Am J Cardiol; 1999 Nov; 84(10):1176-81. PubMed ID: 10569326
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
Beckwith C; Munger MA
Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
[TBL] [Abstract][Full Text] [Related]
8. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party.
Borghi C; Marino P; Zardini P; Magnani B; Collatina S; Ambrosioni E
Am Heart J; 1998 Aug; 136(2):213-25. PubMed ID: 9704681
[TBL] [Abstract][Full Text] [Related]
10. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Mazzotta G; Vecchio C
G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
Young JB
Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
[TBL] [Abstract][Full Text] [Related]
12. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS).
van Gilst WH; Kingma JH; Peels KH; Dambrink JH; St John Sutton M
J Am Coll Cardiol; 1996 Jul; 28(1):114-21. PubMed ID: 8752803
[TBL] [Abstract][Full Text] [Related]
13. Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
Konermann M; Altmann C; Laschewski F; Josephs W; Odenthal HJ; Horstmann E; Sanner B
Clin Cardiol; 1998 Apr; 21(4):277-85. PubMed ID: 9562938
[TBL] [Abstract][Full Text] [Related]
14. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
15. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
Barron HV; Michaels AD; Maynard C; Every NR
J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
[TBL] [Abstract][Full Text] [Related]
16. [The use of angiotensin converting enzyme inhibitors in patients after myocardial infarction].
Kardiologiia; 2008; 48(11):64-8. PubMed ID: 19076083
[TBL] [Abstract][Full Text] [Related]
17. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
Ambrosioni E; Borghi C; Magnani B
N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting-enzyme inhibition in heart failure or after myocardial infarction.
White CM
Am J Health Syst Pharm; 2000 Oct; 57 Suppl 1():S18-25. PubMed ID: 11030019
[TBL] [Abstract][Full Text] [Related]
19. Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Borghi C; Bacchelli S; Esposti DD; Bignamini A; Magnani B; Ambrosioni E
Am J Hypertens; 1999 Jul; 12(7):665-72. PubMed ID: 10411363
[TBL] [Abstract][Full Text] [Related]
20. Influence of prior ACE inhibitor therapy on morbidity and mortality following acute myocardial infarction.
Raggi P; Dickson NR; Boyne M; Pereira R; Cooil B; Wattanasuwan N; Russell DC
Ann Pharmacother; 1998 Nov; 32(11):1141-6. PubMed ID: 9825077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
